CP-506 (HAP)

CP-506 (hypoxia-activated prodrug)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CP-506 (HAP), covering 2025-10-07 to 2025-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI [Phase 1, Phase 2]